Lymphoma chest pain

Lymph is distributed in many parts of the human body. Lymph is a relatively large gland in the body. When the lymph is affected by some diseases, it will cause great harm to the health of the body. Lymphoma is a relatively common disease. When suffering from this disease, patients will experience swollen lymph nodes, fever, itching all over the body and weight loss, and these phenomena will appear in multiple parts of the body.

Lymphoma symptoms

1. Systemic symptoms

Malignant lymphoma may cause systemic symptoms such as fever, itching, night sweats and weight loss before or at the same time as the discovery of swollen lymph nodes.

2.?Immune and blood system manifestations

When malignant lymphoma is diagnosed, 10% to 20% of patients may have anemia. Some patients may have increased white blood cell count, thrombocytosis, and increased erythrocyte sedimentation rate. Some patients may have a leukemoid reaction and a significant increase in neutrophils. Increased lactate dehydrogenase levels were associated with tumor burden. Some patients, especially those in the advanced stage, show abnormal immune function. In B-cell NHL, varying amounts of monoclonal immunoglobulins can be detected in the serum of some patients.

3. Skin lesions

Patients with malignant lymphoma may have a series of nonspecific skin manifestations. The skin lesions are polymorphic, with erythema, blisters, erosions, etc. Patients with advanced malignant lymphoma have low immunity, and skin infections often ulcerate and exude for a long time, forming systemic scattered skin thickening and desquamation.

Lymphoma Treatment

1. Radiation therapy

Some types of lymphoma can be treated with radiation therapy alone in the early stages. Radiotherapy can also be used for consolidation therapy after chemotherapy and adjuvant therapy during transplantation.

2. Chemotherapy

Lymphoma chemotherapy often uses combination chemotherapy, which can combine targeted therapy drugs and biological agents. In recent years, chemotherapy regimens for lymphoma have been greatly improved, and the survival rate of many types of lymphoma has been greatly improved.

3. Bone marrow transplant

For patients under 60 years old who are intermediate- and high-risk and can tolerate high-dose chemotherapy, autologous hematopoietic stem cell transplantation can be considered. Allogeneic hematopoietic stem cell transplantation may also be considered for some young patients with relapse or bone marrow invasion.

4. Surgery

Limited to biopsy or complication treatment; patients with hypersplenism and no contraindications can undergo splenectomy to improve blood counts and create favorable conditions for subsequent chemotherapy.